Prevalence of Diabetic Peripheral Neuropathy among Type I Diabetes – An Observational Study
DOI:
https://doi.org/10.61841/g12vmm41Keywords:
Diabetes, Peripheral Neuropathy, DN4, S-LAANS, MNSIAbstract
Objective: The objective of this study is to find out the prevalence of diabetic peripheral neuropathy (DPN) among diabetics in Chennai.
Background of the Study: DPN is the most common chronic and long-term complication of diabetes mellitus and is considered the leading cause of mortality and morbidity rate, causing a huge economic burden to the government. It is one of the serious microvascular complications of DM, which has been diagnosed in 20-50% of the diabetic population.
Methodology: This is a cross-sectional study with 100 patients selected by the simple random sampling method. Those who were aged more than 30 years and diagnosed positive for type I diabetes for at least 1 year duration with random blood sugar >200 mg/dl as per Indian Council of Medical Research guidelines 2005. Those who were willing to participate and who had regular follow-up visits for at least 6 months were included in this study. The exclusion criteria are those who have type 1 diabetes, gestational DM, and maturity-onset diabetes of the young; significant musculoskeletal disorder in the lower limb; those who underwent amputation of the whole foot, below-knee amputation, and above-knee amputation; and peripheral neuropathy due to any other cause. The prevalence of DPN among diabetics in Chennai will be found out. Pre- and post-tests were done using the DN4, S-LAANS, and MNSI questionnaires.
Result: The study was conducted in type 1 diabetes patient following results were obtained The prevalence was found using the DN4, MNSI, and S-LANSS questionnaires. The mean of DN4 was found to be 4.0800, and it's significant with p<0.05. The mean of MNSI is about 7.62000 with significance p<0.05, and the mean value of S-LANSS is 9.0600 with significance of p<0.05. The overall prevalence of diabetic peripheral neuropathy was found to be 30%.
Downloads
References
[1] WHO Expert committee on diabetes mellitus. Second reprt. Geneva: who, 1980. Technical report series 646.
[2] Hamad Almuhannad Et Al. Diabetic Neuropathy and Painful Diabetic Neuropathy: Cinderella Complications in South East Asia. - Vol.68, No.1, January2018
[3] Irshad Ahmad Et Al. Balance Training In Diabetic Peripheral Neuropathy. JSM Diabetol Manag 2(1): 1002 (2017)
[4] Surendra Darivemula Et Al. Prevalence and its Associated Determinants of Diabetic Peripheral Neuropathy
(DPN) In Individuals Having Type-2 Diabetes Mellitus In Rural South India. Indian J Community Med.
2019 Apr-Jun; 44(2): 88–91.
[5] Ranjit Mohan Anjana Et Al.Causes And Predictors Of Mortality In Asian Indians With And Without
Diabetes–10 Year Follow-Up of the Chennai Urban Rural Epidemiology Study (CURES - 150). Plos One.
2018; 13(7): E0197376
[6] Iftikhar Haider Naqvi Et Al Peripheral Neuropathy and Vasculopathy; Frequency and Associated Risk
Factors In Newly Diagnosed Treatment Naive Type 2 Diabetes. Vol.08 No.05(2018), Article ID:87389
[7] AsmatUllah Et Al Diabetes Mellitus and Oxidative Stress––A Concise Review.
[8] Meenakshisundarisubramaniyan. Natarajan et al awareness of diabetes and its complications among
diabetes patients and their care takers attending a tertiary care hospital in chennai suburban area. J.
Evolution med. Dent. Sci./eissn- 2278-4802, pissn- 2278-4748/ vol. 8/ issue 23/ june 10, 2019.
[9] Kelsey Juster-Switlyk and A. Gordon Smith. Updates in Diabetic Peripheral Neuropathy. Version
1. F1000Res. 2016; 5: F1000 Faculty Rev-738.
[10] Maryam Khan Kundi Et Al Prevalence and Severity of Diabetic Peripheral Neuropathy & Its Impact On
Quality Of Life Of Diabetics In Hayatabad. Int. J. Pathol. 2018;16(4):160-164
[11] Shrestha HK, Katwal PC. Prevalence and Risk Factors of Diabetic Peripheral Neuropathy in T2DM Patient
Presenting To Community Hospital In Nepal. VOL. 15 | NO. 2 | ISSUE 58 | APRIL-JUNE 2017
[12] Casandra J Rosenberg Et Al (2014) Treatment of Painful Diabetic Peripheral Nueropathy.
[13] Brian C. Callaghan Et Al Diabetes And Obesity Are The Main Metabolic Drivers of Peripheral
Neuropathy. Annals of Clinical And Translational Neurology 2018; 5(4): 397–405
[14] Qi Pan Et Al Prevalence of and Risk Factors For Peripheral Neuropathy In Chinese Patients With Diabetes:
A Multicenter Cross-Sectional Study. Front. Endocrinol., 05 November 2018 |
[15] TwahaKisozi Et Al Prevalence, Severity And Factors Associated With Peripheral Neuropathy Among
Newly Diagnosed Diabetic Patients Attending Mulago Hospital: A Cross-Sectional Study. African Health
Sciences Vol 17 Issue 2, June, 2017.
[16] MiMiThet Mon Win Et Al. Prevalence of Peripheral Neuropathy and its Impact on Activities of Daily
Living In People With Type 2 Diabetes.
[17] Georgios Ponirakis Et Al. Prevalence and Risk Factors for Painful Diabetic Neuropathy in Secondary
Healthcare In Qatar. J Diabetes Investig Vol. 10 No. 6 November 2019.
[18] Sinan ma al-mahmood et al. Factors influencing the severity of pain in patients with peripheral diabetic
neuropathy. Vol 10, issue 10, 2017.
[19] Maryam Khan Kundi Et Al Prevalence and Severity of Diabetic Peripheral Neuropathy & Its Impact On
Quality Of Life Of Diabetics In Hayatabad, Peshawar. Int. J. Pathol. 2018; 16(4):160-164.
[20] Singh, Shilpi, et al. "Hypoglycemic Profile of Gymnemic Acid and Glycyrrhizic Acid on High Fructose
Diet Related Obesity Induced Diabetes." International Journal of Medicine and Pharmaceutical Science
(IJMPS) ISSN (P) (2016): 2250-0049.
[21] Michael I. Bennett et al., the S-LANSS score for identifying pain of predominantly neuropathic
origin:validation for use in clinical and postal research. The journal of pain, vol 6, No 3(march),2005:pp
149-158.
[22] Akinsola, V. O., and T. O. Oluyo. "A note on the divergence of the numerical solution of the mathematical
model for the burden of diabetes and its complications using euler method." Int J Math ComputAppl
Res 5.3 (2015): 93-100.
[23] W.H.Herman et al., Use of the Michigan neuropathy screening instrument as a measure of distal
symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications
trial. Epidermiology of diabetes interventions and complications. diabet med., 2012 jul;29(7):937-944.
[24] Rao, T. INDIRA, and HONGSANDRA RAMARAO Nagendra. "The effect of active and silent music
interventions on patients with type 2 diabetes measured with electron photonic imaging technique." Int J
Humanit Soc Sci 3 (2014): 7-14.
[25] Isin Unal -Cevik et al., A comparison of the DN4 and LANSS questionnaires in the assessment of
neuropathic pain: validity and reliability of the Turkish version of DN4. The journal of pain, vol 11, No 11
(November), 2010: pp 1129-1135.
[26] Akinsola, V. O., and T. O. Oluyo."Mathematical model of the complications and control of diabetes
mellitus." Int J Math Comput Appl Res 4.5 (2014): 1-14.
[27] Maryam khan kundi et al., prevalence and severity of diabetic peripheral neuropathy and its impact on
quality of life of diabetics in Hayatabad, Peshawar, Int. j. patjol. 2018; 16(4):160-164.
[28] Ahlam. A. Amour et al., prevalence, pattern and factors associated with peripheral neuropathies among
diabetic patient at teritary hospital in the Kilimanjaro region: descriptive cross sectional study from North
eastern tanzania. Volume 2019, article ID 5404781.
[29] Ajani, A. K. I. N. L. O. L. U., and BAKARE OLALEKAN Olanrewaju. "Avocado pear fruits and leaves
aqueous extracts inhibit α-amylase, α-glucosidase and snp induced lipid peroxidation–an insight into
mechanisms involve in management of type 2 diabetes." Int J Appl Nat Sci, 3, 21 34 (2014).
[30] Department of non-communicable diseases et al., prevalence and determinants of pheripheral neuropathy
among urban and rural Bangladeshi type 2 diabetic subjects. Annals of neurology 82, s72-s72, 2017.
[31] Twahakisozi et al., prevalence,severity and factors associated with peripheral Neuropathy among newly
diagnosed diabetic patients attending Mulagohospital:a cross sectional study. African health sciences vol 17
issue 2, june, 2017.
[32] Rao, YELURI SESHAGIRI, and VANAMALI DHARMA RAO."Prevalence of Periodontitis among
patients with Type-2 Diabetes Mellitus." Int J Gen Med Phrar, 5 (2), 15 22 (2016).
[33] Nahlakhawaja et al., The prevalence and risk factors of peripheral neuropathy among patients with type 2
diabetes mellitus; the case of jordan. ISSN: 1758-5996.
[34] Gill HK et al., A prospective study of prevalence and association of pheripheral neuropathy in Indian
patients with newly diagnosed type 2 diabetes mellitus. Journal of post graduate medicine july 2014 vol 60
issue 3.
[35] Javadkiani MD et al., The prevalence and assocaiated risk factors of peripheral diabetic neuropathy in
Hamedan, Iran. Arch Iran med. 2013;16(1):17-19.
[36] Mamta Jaiswal et al., prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1
and type 2 diabetes: SEARCH for diabetes in youth study. Diabetes care 2017; 40: 1226-1232.
[37] S Jambart et al., prevalence of painful peripheral neuropathy among patients with diabetes mellitus in the
middle east region. The journal of international medical research 2011; 39: 366-377.
[38] EBRAHIM, SAMIRA MUHAMMED, UTOOR TALIB JASSIM, and DOAA MOHAMMED BAJI. "A
study to assess the attitude and practice of diabetic patient towards self-administration of insulin in basra
city, Iraq." International Journal of General Medicine and Pharmacy (IJGMP) 3.4 (2014): 65-74.
[39] Prasad katulanda et al., The prevalence, patterns and predictors of diabetic peripheral neuropathy in a
developing country. doi:1186/1758-5996-4-21.
[40] AktarReyhanioglu D et al., Turkish validity and reliability of the michigan neuropathy screening instruments. Turk J med sci., 2020 mar 17.doi:10.3906/sag-1906-63.
[41] Yuka Matsuki et al., Reliability and validity of the Japanese translation of the DN4 diagnostic questionnaire in patients with neuropathic pain. https://doi.org/10.1007/S00540-018-2495-7.
[42] Rabiakoc et al., validity and reliability of the Turkish self-administered leeds assessment of neuropathic symptoms and signs (SLAANS) questionnaire. https://doi.org/ 10.1016/ j.nrleng. 2016.10.003.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
